DHR

Danaher had another somewhat uneventful quarter. Looking at Danaher’s numbers every quarter is a stark reminder just how anemic the growth has proved to be for a company that enjoys some supposedly secular tailwinds. Even if you adjust for their spin-off of Environmental & Applied solutions segment in 2023,

Following Sartorius 3Q’25 call, I mentioned in my update that I am actually a bit surprised that Danaher stock didn’t react more positively. Well, Danaher stock did pop ~8% after confirming bioprocessing’s continued growth and an initial 2026 guide that outlined HSD earnings growth even in a

While S&P 500 is at its all-time high, Danaher is still ~34% below its peak from late 2021. The company was beleaguered with pandemic hangover and destocking trends for much of 2022-24 period. While the worst seem to behind them, the business isn’t quite humming enough to